Article citationsMore>>

S. Nissen, K. Wolski and E. Topol, “Effect of Muraglitazar on Death and Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus,” JAMA, Vol. 294, No. 20, 2005, pp. 1-6. doi:10.1001/jama.294.20.joc50147

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top